DEA could reclassify marijuana to a less restrictive category. A drug policy expert weighs the pros and cons

The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden’s call to reclassify marijuana, moving it from the tightly controlled Schedule I category that it has been in since 1970 to the less restrictive Schedule III status of the Controlled Substances Act. That triggered a long process of hearings and reviews that will not be completed until after the presidential election in November.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup